Clinical outcome of immunotherapy with dendritic cell vaccine and cytokine‐induced killer cell therapy in hepatobiliary and pancreatic cancer

2022-04-11T10:07:44+00:00April 11th, 2022|

Clinical outcome of immunotherapy with dendritic cell vaccine and cytokine‐induced killer cell therapy in hepatobiliary and pancreatic cancer Overall survival CONTACT US Summary The goal of this study was [...]

Effects of Dendritic Cell-activated and Cytokine-induced Killer Cell Therapy on 22 Children with Acute Myeloid Leukemia after Chemotherapy

2022-03-23T12:05:49+00:00March 23rd, 2022|

Effects of Dendritic Cell-activated and Cytokine-induced Killer Cell Therapy on 22 Children with Acute Myeloid Leukemia after Chemotherapy AML cancer cells CONTACT US Summary This study investigated the efficiency [...]

A phase I/IIa study of adjuvant immunotherapy with tumour antigen-pulsed dendritic cells in patients with hepatocellular carcinoma

2022-03-23T11:31:15+00:00March 23rd, 2022|

A phase I/IIa study of adjuvant immunotherapy with tumour antigen-pulsed dendritic cells in patients with hepatocellular carcinoma Survival time CONTACT US Summary This study evaluated the safety and efficacy [...]

Combination of External Beam Radiation (EBRT) with Intratumoral Injection of Dendritic Cells as Neo-Adjuvant Treatment of High-Risk Soft Tissue Sarcoma Patients

2022-03-23T10:25:00+00:00March 23rd, 2022|

Combination of External Beam Radiation (EBRT) with Intratumoral Injection of Dendritic Cells as Neo-Adjuvant Treatment of High-Risk Soft Tissue Sarcoma Patients Before & after treatment CONTACT US Summary The [...]

A Phase I/II Clinical Trial Wilms’ Tumor Gene 1 (WT1) – loaded Dendritic Cell Immunotherapy in Patients with Uterine Tumors

2022-03-10T15:33:27+00:00March 10th, 2022|

A Phase I/II Clinical Trial Wilms’ Tumor Gene 1 (WT1) – loaded Dendritic Cell Immunotherapy in Patients with Uterine Tumors Uterus CONTACT US Summary In this study pre-treated patients [...]

Go to Top